ADGRV1
protein-codingadhesion G protein-coupled receptor V1, the group of USH2 complex |Adhesion G protein-coupled receptors, subfamily V
Gene summary
This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]
- USH2C
- MASS1
- GPR98
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~635.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0011443
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0011558
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011558
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0011443
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0016484
Submitter: ClinGen
Inheritance Pattern: AR
Disease ID:MONDO:0019497
Submitter: ClinGen
ADGRV1, previously known as GPR98, was first reported in relation to autosomal recessive nonsyndromic hearing loss in 2013 (Yang et al., 23767834). At least 27 unique variants (missense, nonsense, frameshift, splice-site) have been reported in humans. Variants in this gene have been reported in at least 17 probands in 11 publications (23804846, 24123792, 23767834, 25528277, 25719458, 24853665, 29048421, 26226137, 26445815, 27068579, 28951997). Evidence disputing this gene-disease relationship includes lack of age information, lack of clinical examination history, and high allele frequency of variants in population databases. Of note, this gene has also been implicated in Usher syndrome Type 2. This has been assessed separately as Definitive. The mechanism of disease of ADGRV1-Usher syndrome Type 2 is homozygous loss of function, which is consistent with the variants reported in ADGRV1-nonsyndomic hearing loss patients. In summary, there is convincing evidence disputing the relationship between ADGRV1 and autosomal recessive nonsyndromic hearing loss. More evidence is needed to either support or refute the role ADGRV1 plays in this disease. This classification was approved by the ClinGen Hearing Loss Working Group on 3/19/19 (SOP Version 6).
Inheritance Pattern: AR
Disease ID:MONDO:0016484
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011558
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Neurologic; Ophthalmologic
Intervention: Audiologic/Otolaryngologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
Comments: Digenic inheritance has been described (with PDZD7)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ADGRV1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_032119.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 28 | 1836 | 19 | 1884 | |
| missense | 3 | 31 | 2196 | 1038 | 48 | 3316 |
| nonsense | 142 | 73 | 2 | 217 | ||
| start loss | 1 | 1 | 2 | |||
| frameshift | 234 | 121 | 6 | 361 | ||
| splice donor/acceptor (+/-2bp) | 21 | 100 | 5 | 126 | ||
| Total | 401 | 326 | 2238 | 2874 | 67 | 5906 |
Highest pathogenic variant AF is 0.000077022174
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_115495.3 | 90 | MANE Select | |
| Ensembl | ENSP00000384582.2 | 90 | MANE Select | |
| Ensembl | ENSP00000392618.3 | 38 | Standard | |
| Ensembl | ENSP00000492054.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- GPCRs, Other
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000405460
- Coding exons
- 90
- Length
- 634878
- Individuals with no LoFs
- 124366
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 313
- Defined
- 124679
- p
- 0.00126
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0740 | 3130 | 3.14e+3 | 0.996 | 0.000160 | 41060 |
| Missense (PolyPhen) | 852 | 944.78 | 0.9018 | 12042 | ||
| Synonymous | -0.554 | 1179 | 1.16e+3 | 1.02 | 0.0000632 | 12548 |
| Loss of Function | 8.19 | 110 | 250 | 0.441 | 0.0000132 | 3267 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0013 | 0.0013 | notable |
| Latino/Admixed American | 0.00099 | 0.00099 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0014 | 0.0013 | notable |
| Finnish | 0.00061 | 0.00060 | rare |
| European (Non-Finnish) | 0.0014 | 0.0014 | notable |
| South Asian | 0.0019 | 0.0018 | notable |
| Other | 0.0017 | 0.0017 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Receptor that may have an important role in the development of the central nervous system.;
- Disease
- DISEASE: Usher syndrome 2C (USH2C) [MIM:605472]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses. {ECO:0000269|PubMed:14740321, ECO:0000269|PubMed:22147658}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Febrile seizures, familial, 4 (FEB4) [MIM:604352]: Seizures associated with febrile episodes in childhood without any evidence of intracranial infection or defined pathologic or traumatic cause. It is a common condition, affecting 2-5% of children aged 3 months to 5 years. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.170
Intolerance Scores
- RVIS EVS
- 8.12
- RVIS percentile EVS
- 99.95
Essentials
- Essential (gene trap)
- N